Survival after autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Pluripotent Stem Cells Bone Marrow T-Lymphocytes Neural Stem Cells Bone Marrow Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Spermatogonia Neoplastic Stem Cells Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases54

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Leukemia, Myeloid Neoplasm Recurrence, Local Leukemia Acute Disease Neutropenia Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Neoplasms Lymphoma, AIDS-Related Neuroblastoma Hematologic Diseases Stomatitis Breast Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Anemia, Aplastic Mucositis Infection Severe Combined Immunodeficiency Medulloblastoma Chromosome Aberrations Lymphoproliferative Disorders Leukemia, Lymphocytic, Chronic, B-Cell Opportunistic Infections Disease Models, Animal Postoperative Complications Central Nervous System Neoplasms Thrombocytopenia Blood Group Incompatibility Paraproteinemias Chronic Disease Liver Failure Bronchiolitis Obliterans Mycoses

Chemicals and Drugs49

Melphalan Etoposide Myeloablative Agonists Cytarabine Cyclophosphamide Carmustine Vincristine Thiotepa Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Doxorubicin Antigens, CD34 Antineoplastic Agents, Alkylating Thalidomide Prednisone Ifosfamide Podophyllotoxin Granulocyte Colony-Stimulating Factor Antineoplastic Agents Idarubicin Mitoxantrone Immunosuppressive Agents Antibodies, Monoclonal Keratins, Type II Carboplatin Immunoglobulin Light Chains Vidarabine Cisplatin HLA Antigens Antilymphocyte Serum Immunoconjugates Stem Cell Factor Bleomycin Cyclosporine Recombinant Proteins Minor Histocompatibility Antigens Methotrexate Antigens, CD Tacrolimus Prednisolone Antigens, CD20 Biological Markers Immunologic Factors Nitrogen Mustard Compounds Myeloma Proteins Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment93

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Remission Induction Disease-Free Survival Salvage Therapy Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Retrospective Studies Whole-Body Irradiation Prognosis Follow-Up Studies Liver Transplantation Mesenchymal Stem Cell Transplantation Leukapheresis Induction Chemotherapy Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Blood Component Removal Histocompatibility Testing Prospective Studies Feasibility Studies Life Tables Fatal Outcome Heart Transplantation Risk Factors Radioimmunotherapy Lung Transplantation Kaplan-Meier Estimate Drug Administration Schedule Immunotherapy Blood Transfusion, Autologous Organ Transplantation Neoplasm Staging Transplantation, Isogeneic Lymphocyte Transfusion Clinical Trials as Topic Flow Cytometry Transplantation Islets of Langerhans Transplantation Immunosuppression Treatment Failure Pilot Projects Lymphocyte Depletion Positron-Emission Tomography Cell Separation Predictive Value of Tests Pancreas Transplantation Immunophenotyping Proportional Hazards Models Platelet Count Transplantation, Heterologous Multivariate Analysis Cell Culture Techniques Severity of Illness Index Donor Selection Randomized Controlled Trials as Topic Immunomagnetic Separation Stem Cell Research Cohort Studies Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Disease Models, Animal Leukocyte Count Transplantation, Heterotopic Immunohistochemistry Colony-Forming Units Assay Radiotherapy Incidence Reverse Transcriptase Polymerase Chain Reaction Immunotherapy, Adoptive Polymerase Chain Reaction Heart-Lung Transplantation Cell Count Lymphocyte Count Platelet Transfusion Actuarial Analysis Blood Cell Count Drug Therapy Coculture Techniques Skin Transplantation

Psychiatry and Psychology1

Phenomena and Processes28

Graft Survival Time Factors Cell Survival Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Graft Rejection Stem Cell Niche Dose-Response Relationship, Drug Graft vs Tumor Effect Chimerism Cell Lineage Cell Proliferation Platelet Count Regeneration Transplantation Tolerance Immunocompromised Host Chromosome Aberrations Virus Activation Leukocyte Count Cell Count Lymphocyte Count Phenotype Signal Transduction Drug Resistance, Neoplasm Blood Cell Count

Disciplines and Occupations2

Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Siblings Quality of Life Survival

Humanities1

Quality of Life

Information Science4

Survival Rate Life Tables Fatal Outcome Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Life Tables Fatal Outcome Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Age Factors Predictive Value of Tests Proportional Hazards Models Multivariate Analysis Severity of Illness Index Donor Selection Randomized Controlled Trials as Topic Cohort Studies Incidence Tissue and Organ Procurement Actuarial Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Remission Induction Stem Cells Disease-Free Survival Salvage Therapy Survival Rate Hodgkin Disease Etoposide Myeloablative Agonists Lymphoma, Non-Hodgkin Recurrence Cytarabine Cyclophosphamide Carmustine Graft vs Host Disease Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Vincristine Bone Marrow Purging Thiotepa Survival Analysis Hematologic Neoplasms Retrospective Studies Lymphoma, Mantle-Cell Graft Survival Whole-Body Irradiation Amyloidosis Hematopoietic Stem Cells Busulfan Boronic Acids Dexamethasone Pyrazines Prognosis Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Follow-Up Studies Liver Transplantation Autografts Doxorubicin Antigens, CD34 Lymphoma, T-Cell, Peripheral Antineoplastic Agents, Alkylating Thalidomide Mesenchymal Stem Cell Transplantation Time Factors Prednisone Ifosfamide Leukapheresis Podophyllotoxin Granulocyte Colony-Stimulating Factor Lymphoma Transplantation Chimera Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse Tissue Donors Neoplasm, Residual Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Antineoplastic Agents Leukemia, Myeloid, Acute Kidney Transplantation Embryonic Stem Cells Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Infusions, Spinal Idarubicin Adult Stem Cells Mitoxantrone Neoplasms, Second Primary Immunosuppressive Agents Blood Component Removal Histocompatibility Testing Prospective Studies Cell Survival Cell Differentiation Antibodies, Monoclonal Keratins, Type II Feasibility Studies Histocompatibility Life Tables Leukemia, Myeloid Mesenchymal Stromal Cells Neoplasm Recurrence, Local Carboplatin Fatal Outcome Heart Transplantation Risk Factors

No FAQ available that match "survival after autologous stem cell transplantation"